UCSF has joined a growing network devoted to combating primary hyperoxaluria. As part of this initiative, patients can now ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

We can see that Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) does use debt in its business. But is this debt a concern to shareholders? Debt assists a business until the business has trouble paying it ...

The SPDR S&P Biotech ETF tracks the performance of the S&P Biotechnology Select Industry Index. XBI includes both early-stage ...

Komodo Health, the leader in AI-powered healthcare intelligence, today launched Marmot™, the first healthcare-native AI engine built to serve as the foundational intelligence layer for the discovery, ...

Most recently, she served as General Counsel at PepGen. Prior to that, she spent 15 years in roles of increasing ...

Discover how rising healthcare spending can be turned into income growth. Build a retirement portfolio that thrives in a key ...

Ra Pharmaceuticals, Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, Wuhan Createrna Science and Technology, CANbridge, Attune Pharmaceuticals, RallyBio and others. DelveInsight is a leading ...

In June 2025, Merck announced positive topline results from the first two Phase 3 CORALreef trials evaluating enlicitide decanoate, a potentially first-in-class oral PCSK9 inhibitor. The trials ...

Perhaps most notably, Alnylam reported adjusted earnings per share of $0.32, significantly outperforming analyst expectations of a $0.59 loss. This substantial beat prompted management to raise ...

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca ...

Shares of Charles River Laboratories International Inc. slid 3.16% to $154.54 Thursday, on what proved to be an all-around ...